Target intelligence / Profile preview

Subcutaneous tissue

Molecular classification
Other
01

Overview

Subcutaneous tissue, also known as the hypodermis, is the deepest layer of the skin and is composed primarily of adipose (fat) cells and connective tissue[1][4][5][8]. It functions as the body's main site for fat storage, provides thermal insulation, protects internal organs and muscles from physical trauma, serves as an energy reservoir, and connects the skin to the underlying muscles and bones[3][4][8]. Other functions include hormone production (such as leptin), facilitation of wound healing, and playing a role in immune response and metabolic regulation[2][3]. The subcutaneous layer is not a molecular target like a receptor or enzyme, but rather a tissue structure. It is important in many diseases, including metabolic syndrome, diabetes, certain skin disorders, and neoplastic conditions[2]. Medications can be administered via the subcutaneous route for slow absorption, but the tissue itself is not a drug target[4]. Note: - Subcutaneous tissue is not a molecule, receptor, enzyme, or other typical therapeutic target. - The entry is incorrect as a \"target\"—it refers to a tissue, not a molecule or protein amenable to direct drug targeting[1][2][3][4][5][8]. - No canonical abbreviation exists; standard nomenclature uses the full names or synonyms such as \"hypodermis\" or \"subcutis\". - Functions and disease roles reflect tissue-level biology, not targeted pharmacology. - No known interacting drugs or molecular mechanisms of drug action directly related to \"subcutaneous tissue\".

Other names
HypodermisSubcutisSuperficial fasciaTela subcutanea
02

Biological functions

InsulationShock absorptionEnergy storageThermoregulationStructural supportHormone (e.g., leptin) productionImmune modulationWound healing
03

Disease associations

DiabetesCardiovascular diseaseOsteoarthritisCancerInflammatory skin diseases (e.g., psoriasis, hidradenitis suppurativa)Cutaneous and systemic infections

Beyond the preview

Go deeper on Subcutaneous tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Subcutaneous tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call